Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?

EuroIntervention. 2023 Apr 24;18(17):1471-1472. doi: 10.4244/EIJ-D-22-00821.

Authors

Enrico Fabris¹, Arnoud W J van 't Hof^{2

3

4}

Affiliations

¹ Cardiothoracovascular Department, University of Trieste, Trieste, Italy.
² University Medical Center Maastricht, Maastricht, the Netherlands.
³ Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands.
⁴ Zuyderland Hospital, Heerlen, the Netherlands.

PMID: 37092266
DOI: 10.4244/EIJ-D-22-00821

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use
Drug Therapy, Combination
Heparin / therapeutic use
Humans
Myocardial Infarction* / therapy
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors / therapeutic use
Treatment Outcome

Substances

Heparin
Platelet Aggregation Inhibitors
Anticoagulants